Get the latest Binding Site information

Results Found:
Onco Tracker Collaboration

sBCMA test may both monitor and predict outcomes in multiple myeloma and other blood cancers ONCOtracker.
iStopmm Trial Methods Paper Publication

Binding site is pleased to announce that the methods paper for the landmark iStopMM (Iceland Screens, Treats or Prevents Multiple Myeloma) study has now been published.
Launch of the EXENT® Solution with IVDR Certification Announced

Transforming monoclonal gammopathy management to address an unmet clinical need through an innovative mass spectrometry solution.
Mark Stevenson

The Binding Site, a global leader in specialist protein diagnostics, has appointed Mark Stevenson as new non-executive Chairperson.
Thermo Fisher Scientific to Acquire The Binding Site Group

Expands Specialty Diagnostics Segment with Industry Leader in Oncology Testing for Detection and Monitoring of Multiple Myeloma.